Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
01 1Cayman Pharma s. r. o.
02 1EUROAPI Hungary Ltd.
03 1YS Life Science Co. , Ltd.
01 2Travoprost
02 1Travoprost "production-only"
01 1Czech Republic
02 1France
03 1South Korea
Registration Number : 227MF10153
Registrant's Address : ul. Pra(´)ce 657,277 11 Neratovice, Czech Republic
Initial Date of Registration : 2015-06-01
Latest Date of Registration : 2022-09-14
Registration Number : 227MF10136
Registrant's Address : To(´) utca 1-5. , 1045 Budapest, Hungary
Initial Date of Registration : 2015-05-12
Latest Date of Registration : 2017-01-13
Travoprost "For manufacturing purposes only"
Registration Number : 227MF10195
Registrant's Address : 207, Sujeong-ro, Jangan-myeon, Hwaseong-si, Gyeonggi-do, 18581, Republic of Korea
Initial Date of Registration : 2015-08-03
Latest Date of Registration : 2015-08-03
A Travoprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Travoprost, including repackagers and relabelers. The FDA regulates Travoprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Travoprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Travoprost manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Travoprost supplier is an individual or a company that provides Travoprost active pharmaceutical ingredient (API) or Travoprost finished formulations upon request. The Travoprost suppliers may include Travoprost API manufacturers, exporters, distributors and traders.
click here to find a list of Travoprost suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Travoprost Drug Master File in Japan (Travoprost JDMF) empowers Travoprost API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Travoprost JDMF during the approval evaluation for pharmaceutical products. At the time of Travoprost JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Travoprost suppliers with JDMF on PharmaCompass.
We have 3 companies offering Travoprost
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?